Aims-To investigate the application in immunohistochemistry of y-subunit specific anti-peptide monoclonal antibodies to human neurone specific enolase (NSE); and to determine their reactivity with formalin fixed, wax embedded sections of normal tissue and neuroendocrine tumours. Methods-Immunohistochemical staining was performed on sections of formalin fixed, wax embedded tissue with two monoclonal antibodies (NSE-P1 and NSE-P2) raised against different synthetic peptides specific for the y subunit of human enolase (neurone specific enolase). Results-Both antibodies gave strong immunostaining in normal tissues and cells known to contain NSE. There was no immunoreactivity in tissues containing either the aa or 8il isozymes of enolase. The reactivity of the antibodies with a range of neuroendocrine tumours was also studied and both antibodies gave strong immunostaining of marker of neural and neuroendocrine differentiation in both normal tissues and tumours.5-9
Enolase (2- (NSE) .34 The identification of NSE immunoreactivity, particularly by immunohistochemistry, has made it a general marker of neural and neuroendocrine differentiation in both normal tissues and tumours. [5] [6] [7] [8] [9] There have been few reports of the development of monoclonal antibodies to NSE""'3 presumably reflecting the difficulty of producing antibodies which are y chain specific as the a, /B, and y polypeptides show considerable sequence homology.'4 We have produced monoclonal antibodies to NSE using a novel approach with synthetic peptides specific for the y chain of enolase as immunogens. ' Dako) were sequentially applied for 30 minutes at room temperature. Between each antibody application the sections were washed in TBS to remove unbound antibody. Alkaline phosphatase was demonstrated using an incubating solution consisting of 10 ml 0-05M TRIS-HCI buffer (pH 9 0), 3 mg 5-bromo-4-chloro-3-indolyl phosphate (Sigma), 10 mg nitro blue tetrazolium (Sigma), 20 mg magnesium chloride, 6 mg sodium azide to block endogenous electron transport and 4 mg levamisole to inhibit endogenous alkaline phosphatase. This enzyme substrate solution produces an insoluble blue-black final reaction product. The sections were incubated at room temperature in this solution for 15 minutes and the enzyme reaction was stopped by washing the sections in cold tap water. The sections were then lightly counterstained (optional) in Mayer's haematoxylin, air dried, and mounted in glycerine jelly. All sections were examined by transmitted light microscopy and the distribution and intensity of immunoreactivity recorded.
In one experiment, before application of the anti NSE antibodies, sections were subject to proteolytic enzyme digestion with trypsin. Sections were digested with 0-1% trypsin (type 2, Sigma) for up to 20 minutes at 37°C. The trypsin was prepared as a solution in distilled water containing 0-1% calcium chloride and the pH of the solution adjusted to 7-8 with 0 1M sodium hydroxide immediately before use. The action of trypsin was stopped by washing the sections in cold tap water and TBS.
Results

NORMAL TISSUES
Both anti-NSE antibodies gave a positive immunohistochemical signal on sections of formalin fixed wax embedded tissues. The intensity of the immunostaining with each NSE antibody was similar and the localisation and distribution of immunoreactivity with each antibody was identical. Digestion of sections with trypsin before the NSE antibodies were applied completely abolished all positive immunoreactivity and no immunostaining was observed when the primary antibodies were replaced by TBS.
In brain tissue (cerebral cortex and cerebrellar cortex) strong immunoreactivity was identified within the cytoplasm of nerve cell bodies and their axons and processes (fig 1) . There was no immunoreactivity in glial cells, arachnoid mater, or blood vessels. In the peripheral nervous system NSE immunoreactivity was identified in ganglion cells and peripheral nerve fibres (fig 2) . Chromaffin cells of the adrenal medulla showed strong immunoreactivity while all zones of the adrenal cortex were entirely negative. In the pancreas NSE immunostaining was observed in all the cells within the islets of Langerhans ( fig 3) ; there was no immunoreactivity present in the acini or ducts of the exocrine pancreas. There was no NSE immunoreactivity in either skeletal muscle or liver tissue.
TUMOURS
Different types of neuroendocrine tumours were studied, including islet cell tumours of the pancreas, phaeochromocytomas of the adrenal medulla, carcinoid tumours of the small bowel and appendix and neuroblastomas of the adrenal gland. The various types of neuroendocrine tumours showed an identical localisation and distribution of NSE with the two different anti-NSE antibodies. There was generally strong diffuse cytoplasmic 
Discussion
The glycolytic enzyme enolase consists of several isozymes composed of dimers of three closely related polypeptide chains, and the yy isozyme has been designated neurone specific enolase as it is present in high concentrations in neurones.6 Two monoclonal antibodies were produced using synthetic peptides specific for distinct regions of the y polypeptide chain of enolase.5 The peptides were from external hydrophilic regions which are most likely to be antigenic. An important advantage of using synthetic peptides from p0li Figure 4 Immunohistochemical detection ofNSE in an 
